Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

Behavioral verification and risk factors of HIV cross-population transmission in China: analysis of national surveillance data 1989–2022

Authors: Chang Cai, Houlin Tang, Qianqian Qin, Yichen Jin, Fan Lyu

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Introduction

The dynamic HIV/AIDS epidemic significantly impacts China, particularly affecting injection drug users (IDUs), former plasma donors (FPDs), men who have sex with men (MSM), and those engaging in high-risk heterosexual behavior (HRHB). This study specifically focuses on identifying the risk factors and influences that drive the spread of HIV among these population groups by performing a comprehensive analysis of contact histories of individuals diagnosed with HIV.

Methods

Data for this research were gathered from China’s HIV/AIDS Comprehensive Response Information Management System (CRIMS). Contact histories were described using bar and venn diagram. Trend in engaging in HBRB among MSM were identify potential change using the Cochran-Armitage test. Logistic regression was employed to analyze the factors influencing HBRB in MSM.

Results

From 1989 through to 2022, a total of 1,457,218 individuals aged 15 years or older in China, who reported being infected with HIV, indicated they had one or more types of contact histories including injecting drug use, male homosexual behavior, commercial plasma donation, and high-risk heterosexual behavior. Among these, 97.0% reported a single type of contact history, while 3.0% reported having multiple contact histories. Of those with multiple contact histories, 98.0% (42,258 individuals) had engaged in HRHB. Among all HIV-infected IDUs, MSM, and FPDs, their respective proportions of engagement in HRHB were 11.8%, 5.7% and 6.2%. Prior to 2012, most were reported to be IDUs; however, subsequent to this, most reported being MSM. Factors that heightened the risk of engaging in HRHB among HIV-infected MSM included being of age between 25–34 years [adjusted odds ratio (AOR) = 1.29] or 35–44 years (AOR = 1.22), marital status such as being married (AOR = 1.23) or being divorced/widowed (AOR = 1.17), belonging to an ethnic minority (AOR = 1.29), receiving diagnosis in hospitals (AOR = 1.81), residing in rural areas (AOR = 1.12), among others. However, the risk of HRHB decreased when age ≥ 55 years (55–64 years: AOR = 0.82; ≥ 65 years: AOR = 0.64).

Conclusion

The potential for HIV transmission among diverse populations is substantial. As such, it is imperative that strategies are implemented to mitigate the propagation of HIV to the general populace via heterosexual intercourse.
Literature
8.
go back to reference Ding Y, Ma Z, He J, et al. Evolving HIV Epidemiology in Mainland China: 2009–2018. Curr HIV/AIDS Rep. 2019;16(6):423–30 (10/gsb5n9).CrossRefPubMed Ding Y, Ma Z, He J, et al. Evolving HIV Epidemiology in Mainland China: 2009–2018. Curr HIV/AIDS Rep. 2019;16(6):423–30 (10/gsb5n9).CrossRefPubMed
10.
go back to reference Tang HL, Lv F. Role of bridge population in the transmission of human immunodeficiency virus. Chin J Epidemiol. 2007;28(02):192–4. Tang HL, Lv F. Role of bridge population in the transmission of human immunodeficiency virus. Chin J Epidemiol. 2007;28(02):192–4.
23.
go back to reference Liang Y, Li N, Sun DY, Fan PY, Yang WJ, Nie YG, et al. Characteristics of newly reported HIV/AIDS cases in Henan province, 2010–2018. Chin J Epidemiol. 2020;41(4):532–6 (10/gsdxf3). Liang Y, Li N, Sun DY, Fan PY, Yang WJ, Nie YG, et al. Characteristics of newly reported HIV/AIDS cases in Henan province, 2010–2018. Chin J Epidemiol. 2020;41(4):532–6 (10/gsdxf3).
Metadata
Title
Behavioral verification and risk factors of HIV cross-population transmission in China: analysis of national surveillance data 1989–2022
Authors
Chang Cai
Houlin Tang
Qianqian Qin
Yichen Jin
Fan Lyu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08956-9

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine